Y. Miyazaki et al., AMPLIFICATION OF BCR PROTEIN ASSOCIATED WITH ONCOGENESIS IN HUMAN HEPATOCELLULAR-CARCINOMA, Digestive diseases and sciences, 42(5), 1997, pp. 927-937
The BCR gene is located on human chromosome 22. The normal cellular BC
R gene encodes a 160,000-dalton phosphoprotein associated with a serin
e/threonine kinase activity. The BCR protein is involved in signal tra
nsduction. We investigated the expression of the BCR protein in hepato
cellular carcinoma (HCC), surrounding noncancerous liver tissue, liver
cirrhosis (LC), chronic hepatitis (CH), and normal liver with immunoh
istochemistry and a western blot analysis. BCR immunoreactivity was de
tected using a monoclonal antibody. In normal liver, and both CH and L
C without association of HCC, the immunoreactivity of the BCR protein
was minimal. In contrast, 73% (22 of 30) of noncancerous liver tissue
adjacent to the HCC and 40% (12 of 30) of HCC expressed BCR protein; t
his difference was statistically significant (P < 0.01). The expressio
n of the BCR protein expression correlated with the degree of histolog
ical differentiation of HCC (P < 0.05). In addition, the amplification
of BCR protein in noncancerous cells was supported by the detection o
f specific protein using a western blot analysis. In two cases, the ex
pression of BCR protein occurred only in overtly malignant HCC cells.
As a result, the expression of the BCR protein may be associated with
oncogenesis in human HCC.